Immune status during albendazole therapy for hydatidosis.

Abstract

Immunological monitoring of cystic hydatid patients undergoing medico-surgical management has revealed that it is possible to assess individual host responses throughout therapy and subsequently be guided by the results obtained. The analysis has involved the demonstration of variation in haemagglutination antibodies, specific IgG and IgM immunoglobulins and circulating immune complexes before, during, and months after albendazole therapy.

Cite this paper

@article{Matossian1992ImmuneSD, title={Immune status during albendazole therapy for hydatidosis.}, author={R. M. Matossian and Ghassan N Awar and Hamdan Radwan and Philip Simon Craig and Garbis A. Meshefedjian}, journal={Annals of tropical medicine and parasitology}, year={1992}, volume={86 1}, pages={67-75} }